FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4283072923> ?p ?o ?g. }

• W4283072923 endingPage "27" @default.
• W4283072923 startingPage "22" @default.
• W4283072923 abstract "The extent of intervention effects on carotid intima-media thickness (CIMT) can predict the degree of atherosclerotic cardiovascular risk-reduction. We hypothesized that regular lipoprotein apheresis over the course of 10 years might slow down progression of CIMT in patients with severe hypercholesterolemia. This case series describes 10 Caucasian patients (mean age 60 ± 9 years, 70% female, 80% statin intolerant) with a severe hypercholesterolemia phenotype treated with lipoprotein apheresis between 2005 and 2020 (mean duration, 10 ± 4 years). The median pretreatment low-density lipoprotein cholesterol (LDL-C) level was 214 mg/100 ml (95% confidence interval, 145 to 248), lipoprotein(a) (Lp[a]), 26 mg/100 ml (15 to 109; 40% with Lp(a)>60 mg/100 ml). Three patients were diagnosed with a monogenic cause. The baseline mean CIMT was 850 ± 170 µm, and maximum CIMT was 1,040 ± 220 µm across the age range of 46 to 70 years. Acute effects of lipoprotein apheresis determined as a difference before and immediately after the procedure were estimated as a median of 72 ± 8% and 75 ± 7% reduction in the LDL-C and Lp(a) levels, respectively. Using the imputed trajectories, period-specific on-treatment time-weighted averages for LDL-C and Lp(a) were 141 mg/100 ml (interquartile range, 89 to 152; 38% reduction from the baseline) and 24 mg/100 ml (interquartile range, 12 to 119; 19% reduction from baseline), respectively. The number of patients with CIMT above their “vascular age” decreased from 80% to 30% over the treatment course. In conclusion, an increase in CIMT seen with advanced age and severe hypercholesterolemia was halted with lipoprotein apheresis with an estimated annual rate of change in mean common CIMT of −4 µm/y and maximum CIMT of −3 µm/y. The extent of intervention effects on carotid intima-media thickness (CIMT) can predict the degree of atherosclerotic cardiovascular risk-reduction. We hypothesized that regular lipoprotein apheresis over the course of 10 years might slow down progression of CIMT in patients with severe hypercholesterolemia. This case series describes 10 Caucasian patients (mean age 60 ± 9 years, 70% female, 80% statin intolerant) with a severe hypercholesterolemia phenotype treated with lipoprotein apheresis between 2005 and 2020 (mean duration, 10 ± 4 years). The median pretreatment low-density lipoprotein cholesterol (LDL-C) level was 214 mg/100 ml (95% confidence interval, 145 to 248), lipoprotein(a) (Lp[a]), 26 mg/100 ml (15 to 109; 40% with Lp(a)>60 mg/100 ml). Three patients were diagnosed with a monogenic cause. The baseline mean CIMT was 850 ± 170 µm, and maximum CIMT was 1,040 ± 220 µm across the age range of 46 to 70 years. Acute effects of lipoprotein apheresis determined as a difference before and immediately after the procedure were estimated as a median of 72 ± 8% and 75 ± 7% reduction in the LDL-C and Lp(a) levels, respectively. Using the imputed trajectories, period-specific on-treatment time-weighted averages for LDL-C and Lp(a) were 141 mg/100 ml (interquartile range, 89 to 152; 38% reduction from the baseline) and 24 mg/100 ml (interquartile range, 12 to 119; 19% reduction from baseline), respectively. The number of patients with CIMT above their “vascular age” decreased from 80% to 30% over the treatment course. In conclusion, an increase in CIMT seen with advanced age and severe hypercholesterolemia was halted with lipoprotein apheresis with an estimated annual rate of change in mean common CIMT of −4 µm/y and maximum CIMT of −3 µm/y." @default.
• W4283072923 created "2022-06-19" @default.
• W4283072923 creator A5001122371 @default.
• W4283072923 creator A5002852988 @default.
• W4283072923 creator A5016701722 @default.
• W4283072923 creator A5041331057 @default.
• W4283072923 creator A5050387718 @default.
• W4283072923 creator A5065555595 @default.
• W4283072923 date "2022-08-01" @default.
• W4283072923 modified "2023-09-26" @default.
• W4283072923 title "Effect of Lipoprotein Apheresis on Progression of Carotid Intima-Media Thickness in Patients with Severe Hypercholesterolemia" @default.
• W4283072923 cites W1970484759 @default.
• W4283072923 cites W2015124783 @default.
• W4283072923 cites W2049170821 @default.
• W4283072923 cites W2069151290 @default.
• W4283072923 cites W2090053444 @default.
• W4283072923 cites W2100563697 @default.
• W4283072923 cites W2102964115 @default.
• W4283072923 cites W2106505662 @default.
• W4283072923 cites W2114128165 @default.
• W4283072923 cites W2129837832 @default.
• W4283072923 cites W2147281279 @default.
• W4283072923 cites W2411760145 @default.
• W4283072923 cites W2767963750 @default.
• W4283072923 cites W2802582783 @default.
• W4283072923 cites W2980876689 @default.
• W4283072923 cites W3033917691 @default.
• W4283072923 cites W3037162135 @default.
• W4283072923 cites W4210441743 @default.
• W4283072923 doi "https://doi.org/10.1016/j.amjcard.2022.05.002" @default.
• W4283072923 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35718549" @default.
• W4283072923 hasPublicationYear "2022" @default.
• W4283072923 type Work @default.
• W4283072923 citedByCount "2" @default.
• W4283072923 countsByYear W42830729232023 @default.
• W4283072923 crossrefType "journal-article" @default.
• W4283072923 hasAuthorship W4283072923A5001122371 @default.
• W4283072923 hasAuthorship W4283072923A5002852988 @default.
• W4283072923 hasAuthorship W4283072923A5016701722 @default.
• W4283072923 hasAuthorship W4283072923A5041331057 @default.
• W4283072923 hasAuthorship W4283072923A5050387718 @default.
• W4283072923 hasAuthorship W4283072923A5065555595 @default.
• W4283072923 hasConcept C119060515 @default.
• W4283072923 hasConcept C126322002 @default.
• W4283072923 hasConcept C164705383 @default.
• W4283072923 hasConcept C2776104379 @default.
• W4283072923 hasConcept C2776738589 @default.
• W4283072923 hasConcept C2778163477 @default.
• W4283072923 hasConcept C2779120738 @default.
• W4283072923 hasConcept C2779339615 @default.
• W4283072923 hasConcept C2780072125 @default.
• W4283072923 hasConcept C2987047532 @default.
• W4283072923 hasConcept C44249647 @default.
• W4283072923 hasConcept C71924100 @default.
• W4283072923 hasConcept C89560881 @default.
• W4283072923 hasConceptScore W4283072923C119060515 @default.
• W4283072923 hasConceptScore W4283072923C126322002 @default.
• W4283072923 hasConceptScore W4283072923C164705383 @default.
• W4283072923 hasConceptScore W4283072923C2776104379 @default.
• W4283072923 hasConceptScore W4283072923C2776738589 @default.
• W4283072923 hasConceptScore W4283072923C2778163477 @default.
• W4283072923 hasConceptScore W4283072923C2779120738 @default.
• W4283072923 hasConceptScore W4283072923C2779339615 @default.
• W4283072923 hasConceptScore W4283072923C2780072125 @default.
• W4283072923 hasConceptScore W4283072923C2987047532 @default.
• W4283072923 hasConceptScore W4283072923C44249647 @default.
• W4283072923 hasConceptScore W4283072923C71924100 @default.
• W4283072923 hasConceptScore W4283072923C89560881 @default.
• W4283072923 hasFunder F4320332445 @default.
• W4283072923 hasLocation W42830729231 @default.
• W4283072923 hasLocation W42830729232 @default.
• W4283072923 hasOpenAccess W4283072923 @default.
• W4283072923 hasPrimaryLocation W42830729231 @default.
• W4283072923 hasRelatedWork W2015077190 @default.
• W4283072923 hasRelatedWork W2029789115 @default.
• W4283072923 hasRelatedWork W2093967830 @default.
• W4283072923 hasRelatedWork W2159236706 @default.
• W4283072923 hasRelatedWork W2403559284 @default.
• W4283072923 hasRelatedWork W3039853434 @default.
• W4283072923 hasRelatedWork W3177249677 @default.
• W4283072923 hasRelatedWork W3213459262 @default.
• W4283072923 hasRelatedWork W4283072923 @default.
• W4283072923 hasRelatedWork W2016060162 @default.
• W4283072923 hasVolume "177" @default.
• W4283072923 isParatext "false" @default.
• W4283072923 isRetracted "false" @default.
• W4283072923 workType "article" @default.